D Guyotat

986 total citations
52 papers, 659 citations indexed

About

D Guyotat is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, D Guyotat has authored 52 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 16 papers in Genetics and 13 papers in Oncology. Recurrent topics in D Guyotat's work include Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (7 papers). D Guyotat is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (7 papers). D Guyotat collaborates with scholars based in France, Switzerland and United States. D Guyotat's co-authors include Lydia Campos, D Fière, E Archimbaud, Gilles Thuret, Philippe Gain, Brigitte Tardy, N. Roubi, Carmen Aanei, B. Tardy-Poncet and Martine Ffrench and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

D Guyotat

51 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Guyotat France 16 274 153 142 121 119 52 659
J. L. Harousseau France 14 436 1.6× 163 1.1× 187 1.3× 293 2.4× 94 0.8× 35 812
C Bayle France 14 185 0.7× 189 1.2× 333 2.3× 264 2.2× 175 1.5× 39 767
Takafumi Matsushima Japan 17 417 1.5× 263 1.7× 266 1.9× 200 1.7× 69 0.6× 57 933
Guido Gini Italy 12 184 0.7× 93 0.6× 241 1.7× 210 1.7× 64 0.5× 37 629
G. J. Ossenkoppele Netherlands 18 309 1.1× 135 0.9× 269 1.9× 308 2.5× 110 0.9× 51 832
Sigal Grisariu Israel 14 239 0.9× 179 1.2× 213 1.5× 246 2.0× 41 0.3× 48 742
Mitsutoshi Kurosawa Japan 13 241 0.9× 176 1.2× 140 1.0× 209 1.7× 40 0.3× 49 610
José R. Valbuena United States 18 185 0.7× 182 1.2× 357 2.5× 204 1.7× 45 0.4× 41 809
Tadashi Koike Japan 16 218 0.8× 127 0.8× 168 1.2× 200 1.7× 43 0.4× 72 856
V Shepherd United Kingdom 14 565 2.1× 121 0.8× 36 0.3× 214 1.8× 88 0.7× 21 747

Countries citing papers authored by D Guyotat

Since Specialization
Citations

This map shows the geographic impact of D Guyotat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Guyotat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Guyotat more than expected).

Fields of papers citing papers by D Guyotat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Guyotat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Guyotat. The network helps show where D Guyotat may publish in the future.

Co-authorship network of co-authors of D Guyotat

This figure shows the co-authorship network connecting the top 25 collaborators of D Guyotat. A scholar is included among the top collaborators of D Guyotat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Guyotat. D Guyotat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heiblig, Maël, Olivier Kosmider, Jérôme Cornillon, et al.. (2023). Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome. HemaSphere. 7(4). e868–e868. 20 indexed citations
2.
Genthon, Alexis, Martin Killian, Philippe Mertz, et al.. (2020). Les myélofibroses. La Revue de Médecine Interne. 42(2). 101–109. 4 indexed citations
3.
Aanei, Carmen, et al.. (2018). Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia. Frontiers in Oncology. 8. 109–109. 18 indexed citations
4.
Aanei, Carmen, Pascale Flandrin‐Gresta, Sylvie Tondeur, et al.. (2017). Potential Role of OCT4 in Leukemogenesis. Stem Cells and Development. 26(22). 1637–1647. 13 indexed citations
5.
Gouill, Steven Le, Nöel Milpied, Vincent Delwail, et al.. (2011). First-line rituximab (R) high-dose therapy (R-HDT) versus R-CHOP14 for young adults with diffuse large B-cell lymphoma: Preliminary results of the GOELAMS 075 prospective multicenter randomized trial.. Journal of Clinical Oncology. 29(15_suppl). 8003–8003. 32 indexed citations
6.
Lissandre, Séverine, Jacques‐Olivier Bay, Jean‐Yves Cahn, et al.. (2008). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) as a Curative Therapy in Primary and Secondary Myelofibrosis (MF): A 14-Year Period Oligocentric French Experience.. Blood. 112(11). 1756–1756. 1 indexed citations
7.
Hunault, Mathilde, Jean‐Luc Harousseau, Serge Bologna, et al.. (2007). Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial. Haematologica. 92(12). 1623–1630. 25 indexed citations
8.
Cartron, Guillaume, B. Branger, Christian Berthou, et al.. (2005). Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.. PubMed. 90(6). 802–9. 10 indexed citations
9.
Vial, Thierry, C. Guy, M. Zénut, et al.. (2004). Sideroblastic anaemia during fusidic acid treatment. European Journal Of Haematology. 72(5). 358–360. 3 indexed citations
10.
Tardy, Bernard, Brigitte Tardy, S Laporte‐Simitsidis, et al.. (1997). Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double‐blind randomized study. British Journal of Haematology. 96(1). 174–178. 21 indexed citations
11.
Tardy-Poncet, B., J. Reynaud, Bernard Tardy, et al.. (1996). [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].. PubMed. 25(16). 751–5. 3 indexed citations
12.
Campos, Lydia & D Guyotat. (1996). Expression of Thy-1 antigen (CDw90) on adult acute leukemia blast cells [letter]. Blood. 87(1). 413–414. 5 indexed citations
13.
Campos, Lydia, N. Roubi, & D Guyotat. (1995). Definition of Optimal Conditions for Collection and Cryopreservation of Umbilical Cord Hematopoietic Cells. Cryobiology. 32(6). 511–515. 27 indexed citations
14.
Tardy, Bernard, B. Tardy-Poncet, Yves Page, et al.. (1993). Low molecular weight heparin for hickman catheter-induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer. 71(9). 2882–2883. 2 indexed citations
15.
Rimokh, Ruth, C. Vasselon, Françoise Berger, et al.. (1992). t(2; 18) and t(18;22) Variant Chromosomal Translocations in B Cell Malignancies. Leukemia & lymphoma. 8(3). 197–200. 7 indexed citations
16.
Tardy-Poncet, B., Brigitte Tardy, Françoise Grelac, et al.. (1992). Pentosan polysulfate induced thrombocytopenia and thrombosis. Thrombosis Research. 65. S115–S115. 1 indexed citations
17.
Campos, Lydia, Martine Ffrench, & D Guyotat. (1990). Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics.. PubMed. 4(1). 60–2. 8 indexed citations
18.
Archimbaud, E, C Charrin, O Gentilhomme, et al.. (1988). Initial Clonal Acute Lymphoblastic Transformation of Chronic Lymphocytic Leukemia with (11;14) and (8;12) Chromosome Translocations and Acquired Homozygosity. Acta Haematologica. 79(3). 168–173. 6 indexed citations
19.
Fraissinette, Anne de Brugerolle de, et al.. (1988). Culture of putative Langerhans cell bone marrow precursors: characterization of their phenotype.. PubMed. 16(9). 764–8. 26 indexed citations
20.
Coiffier, B, Catherine Sebban, D Fière, et al.. (1985). [Severe quantitative bone marrow insufficiency: results of treatment with high-dose antilymphocyte serum].. PubMed. 14(20). 1127–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. L. Harousseau Breakdown of academic impact, for papers by C Bayle Breakdown of academic impact, for papers by Takafumi Matsushima Breakdown of academic impact, for papers by Guido Gini Breakdown of academic impact, for papers by G. J. Ossenkoppele Breakdown of academic impact, for papers by Sigal Grisariu Breakdown of academic impact, for papers by Mitsutoshi Kurosawa Breakdown of academic impact, for papers by José R. Valbuena Breakdown of academic impact, for papers by Tadashi Koike Breakdown of academic impact, for papers by V Shepherd
Rankless by CCL
2026